Zhonghua Yi Xue Za Zhi. 2024 Jun 4;104(21):1940-1971. doi: 10.3760/cma.j.cn112137-20240222-00374.
Subarachnoid hemorrhage caused by intracranial aneurysm (aneurysmal subarachnoid hemorrhage,aSAH) poses a significant threat to the health of the Chinese people. The prognosis of aSAH patients is poor, with a mortality of up to 50%, which is a public health problem in China. The clinical evaluation, surgical ctrategies, and perioperative management are important parts of clinical management for aSAH patients. This clinical management guideline consists of 112 recommendations on epidemiology, clinical imaging diagnosis, prognosis evaluation, treatment strategies and selection, anesthesia management, perioperative care, and management of special populations with aSAH, aiming to provide clinical guidance for clinical doctors and related professionals.
颅内动脉瘤引起的蛛网膜下腔出血（动脉瘤性蛛网膜下腔出血，aSAH）对中国人民的健康构成重大威胁。aSAH患者预后较差，死亡率高达50%，这在中国是一个公共卫生问题。临床评估、手术策略和围手术期管理是aSAH患者临床管理的重要组成部分。本临床管理指南包含112条关于aSAH的流行病学、临床影像诊断、预后评估、治疗策略与选择、麻醉管理、围手术期护理以及特殊人群管理的建议，旨在为临床医生及相关专业人员提供临床指导。
